Podium Presentation Osteoarthritis

13.3.4 - A 52 week Randomized, Double-Blind Phase 2 Study Of Intra-Articular, Wnt Pathway Inhibitor (SM04690) For Osteoarthritis (ID 9588)

Presentation Number
13.3.4
Topic
Osteoarthritis
Lecture Time
13:57 - 14:06
Session Name
13.3 - Clinical Trials and Outcomes (ID 781)
Corresponding Author
  • J. Tambiah (San Diego, United States of America)
Authors
  • J. Tambiah (San Diego, United States of America)
  • S. Kennedy (San Diego, United States of America)
  • C. Swearingen
  • I. Simsek
  • A. Gomoll (Boston, United States of America)
  • D. Jones
  • M. Jones
  • J. Bergfeld
Disclosure
A.Gomoll, NuTech, Consultant M.Jones, Samumed, Consultant S.Kennedy, Samumed, Employee,Shareholder I. Simsek, Samumed, Employee, Shareholder C.Swearingen, Samumed, Employee,Shareholder J.Tambiah, Samumed, Employee, Shareholder